Technological advancements in NPWT devices have played a pivotal role in their adoption. Portable and user-friendly devices have made it feasible for NPWT to be administered in hospital settings and home healthcare environments. The development of compact, battery-operated devices has enhanced the flexibility of the NPWT application, contributing to its increased adoption. The inclusion of NPWT in clinical practice guidelines and recommendations by reputable healthcare organizations has further legitimized its adoption.
Ongoing educational initiatives aimed at healthcare professionals have driven NPWT adoption. Training programs, workshops, and educational materials help disseminate knowledge about the benefits and proper use of NPWT, fostering confidence among healthcare providers in incorporating this therapy into their practice. The growing number of people with chronic wounds, such as pressure sores and diabetic ulcers, has increased the demand for efficient wound care solutions. NPWT's success in managing these challenging conditions has led to its widespread adoption as a primary modality for treating chronic wounds.
As per the UK government’s report named “Future of an aging population,” by 2040, nearly one in seven people is projected to be over 75. By 2037, there are projected to be 1.42 million more households headed by someone aged 85 or over, an increase of 161% over 25 years. The overall increase in life expectancy in the UK contributes to a larger population of older adults. The growing preference for home healthcare among seniors creates an opportunity for NPWT devices designed for use outside traditional healthcare settings in the UK. As healthcare standards evolve in the UK, there is an increased emphasis on evidence-based practices and advanced wound care solutions. Hence, all these factors will uplift the regional market’s expansion in the coming years.
The Germany market dominated the Europe Negative Pressure Wound Therapy Market, By Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $244.5 million by 2030. The UK market is exhibiting a CAGR of 5.2% during (2023 - 2030). Additionally, The France market would experience a CAGR of 7% during (2023 - 2030).
Based on End-Use, the market is segmented into Hospitals, Homecare, and Others. Based on Product, the market is segmented into Conventional NPWT, and Single-use NPWT. Based on Type, the market is segmented into Pressure Ulcers, Diabetic Foot Ulcers, Venous Leg Ulcers, Burn Wounds, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
List of Key Companies Profiled
- 3M Company
- Talley Group Ltd. (Direct Healthcare Group)
- Smith & Nephew PLC
- Molnlycke Health Care AB
- DeRoyal Industries, Inc.
- ConvaTec Group PLC
- Cardinal Health, Inc.
- HARTMANN Group (Paul Hartmann AG)
- Cork Medical, LLC
Market Report Segmentation
By End-Use- Hospitals
- Homecare
- Others
- Conventional NPWT
- Single-use NPWT
- Pressure Ulcers
- Diabetic Foot Ulcers
- Venous Leg Ulcers
- Burn Wounds
- Others
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Table of Contents
Companies Mentioned
- 3M Company
- Talley Group Ltd. (Direct Healthcare Group)
- Smith & Nephew PLC
- Molnlycke Health Care AB
- DeRoyal Industries, Inc.
- ConvaTec Group PLC
- Cardinal Health, Inc.
- HARTMANN Group (Paul Hartmann AG)
- Cork Medical, LLC
Methodology
LOADING...